|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Interest earned on marketable securities | |||||
| Equity-based compensation | |||||
| Non-cash write-off of intangible assets | |||||
| Loss on disposal of assets | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts and grants receivable | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Deferred revenue | |||||
| Non-operating lawsuit expense | |||||
| Nonoperating lawsuit expense | |||||
| Accrued expenses | |||||
| Operating lease asset and liability | |||||
| Other liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Proceeds from the sale of marketable securities | |||||
| Acquisition of property and equipment | |||||
| Acquisition of intangible assets | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from the sale of private placements | |||||
| Proceeds from warrants exercised | |||||
| Proceeds from the issuance of common stock, net of issuance cost | |||||
| Payments for taxes in RSUs vested | |||||
| Proceeds from warrants exercised, net of issuance cost | |||||
| Proceeds from stock subscription receivable | |||||
| Payments for taxes on RSUs vested and PSUs vested | |||||
| Net cash provided by financing activities | |||||
| Change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental Disclosure of Non-cash Investing and Financing Activities: | |||||
| Dividend attributable to down round feature of warrants | |||||
| Vesting of RSUs into Class A Common Stock | |||||
| Offering costs in accounts payable and accrued expenses | |||||
| Deemed dividend – warrant inducement offers | |||||
Loading...